India Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “India Drug Delivery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the India Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Infusion Systems, Central Venous Catheters and Implantable Ports

The India Drug Delivery Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Drug Delivery Devices Market.
• Global corporate-level profiles of key companies operating within the India Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

India Drug Delivery Devices is segmented as follows –

• Infusion Systems

• Central Venous Catheters

• Implantable Ports

Reasons to Buy

The India Drug Delivery Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

B. Braun Melsungen AG_x000D_
Becton Dickinson and Co_x000D_
Teleflex Inc_x000D_
Baxter International Inc_x000D_
ICU Medical Inc_x000D_
Edwards Lifesciences Corp_x000D_
Vygon SA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Drug Delivery Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Drug Delivery Devices Market, India 11

3.1 Drug Delivery Devices Market, India, Revenue ($m), 2018-2033 11

3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2023 12

3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2023 13

3.4 Drug Delivery Devices Market, India, Revenue ($m), 2018-2033 14

3.5 Drug Delivery Devices Market, India, Volume (Units), 2018-2033 16

3.6 Drug Delivery Devices Market, India, Volume (Units), 2018-2033 17

3.7 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2023 19

4 Central Venous Catheters Market, India 21

4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2023 21

4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2023 22

4.3 Central Venous Catheters Market, India, Revenue ($m), 2018-2033 23

4.4 Central Venous Catheters Market, India, Volume (Units), 2018-2033 25

4.5 Central Venous Catheters Market, India, Average Price ($), 2018-2033 27

4.6 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2023 28

4.7 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2023 29

5 Implantable Ports Market, India 31

5.1 Implantable Ports Market, India, Revenue Mix ($m), 2023 31

5.2 Implantable Ports Market, India, Segment Contribution (%), 2023 32

5.3 Implantable Ports Market, India, Revenue ($m), 2018-2033 33

5.4 Implantable Ports Market, India, Volume (Units), 2018-2033 35

5.5 Implantable Ports Market, India, Average Price ($), 2018-2033 37

5.6 Implantable Ports Market, India, Distribution Share by Revenue ($m), 2023 38

5.7 Implantable Ports Market, India, Company Share by Revenue ($m), 2023 39

6 Infusion Systems Market, India 40

6.1 Infusion Systems Market, India, Revenue Mix ($m), 2023 40

6.2 Infusion Systems Market, India, Segment Contribution (%), 2023 41

6.3 Infusion Systems Market, India, Revenue ($m), 2018-2033 42

6.3.1 Infusion Pump Disposables Market, India, Revenue ($m), by Segment, 2018-2033 44

6.3.2 Infusion Pumps Market, India, Revenue ($m), by Segment, 2018-2033 46

6.4 Infusion Systems Market, India, Volume (Units), 2018-2033 48

6.4.1 Infusion Pump Disposables Market, India, Volume (Units), by Segment, 2018-2033 50

6.4.2 Infusion Pumps Market, India, Volume (Units), by Segment, 2018-2033 52

6.5 Infusion Systems Market, India, Average Price ($), 2018-2033 54

6.6 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2023 55

6.7 Infusion Systems Market, India, Company Share by Revenue ($m), 2023 56

7 Overview of Key Companies in India, Drug Delivery Devices Market 57

7.1 Becton Dickinson and Co 57

7.1.1 Company Overview 57

7.2 B. Braun Melsungen AG 57

7.2.1 Company Overview 57

7.3 Teleflex Inc 57

7.3.1 Company Overview 57

7.4 Baxter International Inc 57

7.4.1 Company Overview 57

8 Drug Delivery Devices Market Pipeline Products 58

9 Financial Deals Landscape 66

9.1 Acquisition 66

9.1.1 Torrent Investments Sells

2.9% Stake in Torrent Pharmaceuticals for USD366.92 Million 66

9.1.2 Cipla and Alkem Laboratories may Acquire Majority Stake in Sahajanand Medical Technologies 67

9.1.3 Consortium of Investors to Acquires 26% Stake in Raymed Labs for USD

0.03 Million 68

9.1.4 Eris Lifesciences to Acquire 100% Stake in Chemman Labs For USD12.54 Million 69

9.2 Equity Offerings 70

9.2.1 Poly Medicure Raises USD1.19 Billion in Private Placement of Shares 70

9.2.2 Morepen Laboratories Raises USD23.86 Million in Qualified Institutional Placement of Shares 72

9.2.3 Torrent Pharma Plans to Raise USD600.5 Million in Private Placement of Shares 75

9.3 Partnerships 76

9.3.1 Aptar Pharma India Enters into Co-Development Agreement with Pulmotree Medical 76

9.3.2 Nestle India to Form Joint Venture With Dr. Reddy’s 77

9.4 Private Equity 79

9.4.1 Platinum Equity Advisors Acquires Majority Stake in Inventia Healthcare from InvAscent Capital and Jacob Ballas Capital India 79

9.4.2 Maiva Pharma Raises USD119.8 Million in Private Financing 81

10 Recent Developments 83

10.1 Corporate Communications 83

10.1.1 Mar 11, 2025: Poly Medicure Receives MDR Certification for 54 Products, Strengthening Its Leadership in Medical Device Industry 83

10.1.2 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 83

10.1.3 Feb 01, 2025: Lupin Announces Closure of Inspection by U.S. FDA at its Somerset Facility with No Observations 83

10.1.4 Sep 02, 2024: Mr. Adil Zainulbhai and Mr. Ashok Sinha Are Completing Their Second Term as an Independent Director on 2nd September 2024 83

10.1.5 Aug 12, 2024: Raymed Labs: Notice of 32nd Annual General Meeting 84

10.1.6 Jul 23, 2024: Torrent Pharmaceuticals : Change in Senior Management Personnel 84

10.1.7 Jun 25, 2024: Closure of US FDA Inspection at Company’s Manufacturing Facility Located at Baddi, India 84

10.1.8 May 07, 2024: Dr. Reddy's Laboratories Announces Dividend and Annual General Meeting 84

10.2 Financial Announcements 85

10.2.1 Nov 11, 2024: Morepen Laboratories Announces Consolidated Financial Results for the and Half Year Ended 30th September 2024 85

10.2.2 Aug 14, 2024: Solasia Pharma Reports Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2024 85

10.2.3 Aug 14, 2024: Glenmark Pharma Reports Consolidated Revenue Growth of

6.9%, EBITDA Margin of

18.1% and PAT Margin of

10.5% YoY for Q1 FY 2024-25 85

10.2.4 Aug 01, 2024: Sun Pharmaceutical Industries Announces Results for Quarter Ended June 30, 2024 86

10.2.5 Jul 16, 2024: Sun Pharma to Announce First Quarter Results on August 01, 2024 86

10.3 Other Significant Developments 86

10.3.1 Sep 30, 2024: Lupin and Scope Sign a Distribution Agreement for the Commercialization of Optase Range of Products in Mexico 86

10.4 Product News 87

10.4.1 Oct 28, 2024: Lupin to focus on the Lupin to Focus on the Development of Inhalers with Near-Zero Global Warming Potential Propellantsof inhalers with near-zero global warming potential propellants 87

11 Appendix 88

11.1 Research Methodology 89

11.1.1 Coverage 89

11.1.2 Secondary Research 89

11.1.3 Primary Research 90

11.1.4 Market Modeling and Forecasting 91

11.1.5 Company Share Analysis 92

11.1.6 Distribution Share Analysis 92

11.1.7 Benchmarking 93

11.2 GlobalData Consulting 93

11.3 Contact Us 93

11.4 Disclaimer 94

Table

Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2023 13

Table 3: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2018-2033 15

Table 4: Drug Delivery Devices Market, India, Volume (Units), 2018-2033 16

Table 5: Drug Delivery Devices Market, India, Volume (Units), 2018-2033 18

Table 6: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2023 20

Table 7: Central Venous Catheters Market, India, Segment Contribution (%), 2023 22

Table 8: Central Venous Catheters Market, India, Revenue ($m), USD Constant, 2018-2033 24

Table 9: Central Venous Catheters Market, India, Volume (Units), 2018-2033 26

Table 10: Central Venous Catheters Market, India, Average Price ($), 2018-2033 27

Table 11: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2023 28

Table 12: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2023 30

Table 13: Implantable Ports Market, India, Segment Contribution (%), 2023 32

Table 14: Implantable Ports Market, India, Revenue ($m), USD Constant, 2018-2033 34

Table 15: Implantable Ports Market, India, Volume (Units), 2018-2033 36

Table 16: Implantable Ports Market, India, Average Price ($), 2018-2033 37

Table 17: Implantable Ports Market, India, Distribution Share by Revenue ($m), USD Constant, 2023 38

Table 18: Implantable Ports Market, India, Company Share by Revenue ($m), USD Constant, 2023 39

Table 19: Infusion Systems Market, India, Segment Contribution (%), 2023 41

Table 20: Infusion Systems Market, India, Revenue ($m), USD Constant, 2018-2033 43

Table 21: Infusion Pump Disposables Market, India, Revenue ($m), USD Constant, 2018-2033 45

Table 22: Infusion Pumps Market, India, Revenue ($m), USD Constant, 2018-2033 47

Table 23: Infusion Systems Market, India, Volume (Units), 2018-2033 49

Table 24: Infusion Pump Disposables Market, India, Volume (Units), 2018-2033 51

Table 25: Infusion Pumps Market, India, Volume (Units), 2018-2033 53

Table 26: Infusion Systems Market, India, Average Price ($), 2018-2033 54

Table 27: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2023 55

Table 28: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2023 56

Table 29: Drug Delivery Devices Market Pipeline Products 58

Table 30: Torrent Investments Sells 2.9% Stake in Torrent Pharmaceuticals for USD366.92 Million 66

Table 31: Cipla and Alkem Laboratories may Acquire Majority Stake in Sahajanand Medical Technologies 67

Table 32: Consortium of Investors to Acquires 26% Stake in Raymed Labs for USD 0.03 Million 68

Table 33: Eris Lifesciences to Acquire 100% Stake in Chemman Labs For USD12.54 Million 69

Table 34: Poly Medicure Raises USD1.19 Billion in Private Placement of Shares 70

Table 35: Morepen Laboratories Raises USD23.86 Million in Qualified Institutional Placement of Shares 72

Table 36: Torrent Pharma Plans to Raise USD600.5 Million in Private Placement of Shares 75

Table 37: Aptar Pharma India Enters into Co-Development Agreement with Pulmotree Medical 76

Table 38: Nestle India to Form Joint Venture With Dr. Reddy’s 77

Table 39: Platinum Equity Advisors Acquires Majority Stake in Inventia Healthcare from InvAscent Capital and Jacob Ballas Capital India 79

Table 40: Maiva Pharma Raises USD119.8 Million in Private Financing 81

Table 41: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country 90

Figures

Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2023 12

Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2023 13

Figure 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2018-2033 14

Figure 5: Drug Delivery Devices Market, India, Volume (Units), 2018-2033 16

Figure 6: Drug Delivery Devices Market, India, Volume (Units), 2018-2033 17

Figure 7: Drug Delivery Devices Market, India, Company Share (%) 2023 19

Figure 8: Central Venous Catheters Market, India, Revenue Mix ($m), 2023 21

Figure 9: Central Venous Catheters Market, India, Segment Contribution (%), 2023 22

Figure 10: Central Venous Catheters Market, India, Revenue ($m), USD Constant, 2018-2033 23

Figure 11: Central Venous Catheters Market, India, Volume (Units), 2018-2033 25

Figure 12: Central Venous Catheters Market, India, Company Share (%) 2023 29

Figure 13: Implantable Ports Market, India, Revenue Mix ($m), 2023 31

Figure 14: Implantable Ports Market, India, Segment Contribution (%), 2023 32

Figure 15: Implantable Ports Market, India, Revenue ($m), USD Constant, 2018-2033 33

Figure 16: Implantable Ports Market, India, Volume (Units), 2018-2033 35

Figure 17: Implantable Ports Market, India, Company Share (%) 2023 39

Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2023 40

Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2023 41

Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, 2018-2033 42

Figure 21: Infusion Pump Disposables Market, India, Revenue ($m), USD Constant, 2018-2033 44

Figure 22: Infusion Pumps Market, India, Revenue ($m), USD Constant, 2018-2033 46

Figure 23: Infusion Systems Market, India, Volume (Units), 2018-2033 48

Figure 24: Infusion Pump Disposables Market, India, Volume (Units), 2018-2033 50

Figure 25: Infusion Pumps Market, India, Volume (Units), 2018-2033 52

Figure 26: Infusion Systems Market, India, Company Share (%) 2023 56

India Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at India Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems in real time.

  • Access a live India Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.